363 related articles for article (PubMed ID: 16299724)
1. Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals.
Zhang L; Zhang F; Yu W; He T; Yu J; Yi CE; Ba L; Li W; Farzan M; Chen Z; Yuen KY; Ho D
J Med Virol; 2006 Jan; 78(1):1-8. PubMed ID: 16299724
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA.
Huang LR; Chiu CM; Yeh SH; Huang WH; Hsueh PR; Yang WZ; Yang JY; Su IJ; Chang SC; Chen PJ
J Med Virol; 2004 Jul; 73(3):338-46. PubMed ID: 15170626
[TBL] [Abstract][Full Text] [Related]
3. A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies.
Faber M; Lamirande EW; Roberts A; Rice AB; Koprowski H; Dietzschold B; Schnell MJ
J Gen Virol; 2005 May; 86(Pt 5):1435-1440. PubMed ID: 15831955
[TBL] [Abstract][Full Text] [Related]
4. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein.
Zhong X; Yang H; Guo ZF; Sin WY; Chen W; Xu J; Fu L; Wu J; Mak CK; Cheng CS; Yang Y; Cao S; Wong TY; Lai ST; Xie Y; Guo Z
J Virol; 2005 Mar; 79(6):3401-8. PubMed ID: 15731234
[TBL] [Abstract][Full Text] [Related]
5. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.
van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J
J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
[TBL] [Abstract][Full Text] [Related]
7. Recombinant protein-based assays for detection of antibodies to severe acute respiratory syndrome coronavirus spike and nucleocapsid proteins.
Haynes LM; Miao C; Harcourt JL; Montgomery JM; Le MQ; Dryga SA; Kamrud KI; Rivers B; Babcock GJ; Oliver JB; Comer JA; Reynolds M; Uyeki TM; Bausch D; Ksiazek T; Thomas W; Alterson H; Smith J; Ambrosino DM; Anderson LJ
Clin Vaccine Immunol; 2007 Mar; 14(3):331-3. PubMed ID: 17229882
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins.
Tripp RA; Haynes LM; Moore D; Anderson B; Tamin A; Harcourt BH; Jones LP; Yilla M; Babcock GJ; Greenough T; Ambrosino DM; Alvarez R; Callaway J; Cavitt S; Kamrud K; Alterson H; Smith J; Harcourt JL; Miao C; Razdan R; Comer JA; Rollin PE; Ksiazek TG; Sanchez A; Rota PA; Bellini WJ; Anderson LJ
J Virol Methods; 2005 Sep; 128(1-2):21-8. PubMed ID: 15885812
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
[TBL] [Abstract][Full Text] [Related]
10. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.
Maache M; Komurian-Pradel F; Rajoharison A; Perret M; Berland JL; Pouzol S; Bagnaud A; Duverger B; Xu J; Osuna A; Paranhos-Baccalà G
Clin Vaccine Immunol; 2006 Mar; 13(3):409-14. PubMed ID: 16522785
[TBL] [Abstract][Full Text] [Related]
11. SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity.
Liang MF; Du RL; Liu JZ; Li C; Zhang QF; Han LL; Yu JS; Duan SM; Wang XF; Wu KX; Xiong ZH; Jin Q; Li DX
Biomed Environ Sci; 2005 Dec; 18(6):363-74. PubMed ID: 16544518
[TBL] [Abstract][Full Text] [Related]
12. [Specific antibodies against the nucleocapsid protein and S1 domain of spike glycoprotein in patients with severe acute respiratory syndrome].
Mei YB; Wang YD; Liao ZY; Hao W; Che XY
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):526-9. PubMed ID: 15949331
[TBL] [Abstract][Full Text] [Related]
13. Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species.
Yu M; Stevens V; Berry JD; Crameri G; McEachern J; Tu C; Shi Z; Liang G; Weingartl H; Cardosa J; Eaton BT; Wang LF
J Immunol Methods; 2008 Feb; 331(1-2):1-12. PubMed ID: 18191140
[TBL] [Abstract][Full Text] [Related]
14. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity.
Buchholz UJ; Bukreyev A; Yang L; Lamirande EW; Murphy BR; Subbarao K; Collins PL
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9804-9. PubMed ID: 15210961
[TBL] [Abstract][Full Text] [Related]
15. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide.
Woo PC; Lau SK; Wong BH; Chan KH; Hui WT; Kwan GS; Peiris JS; Couch RB; Yuen KY
J Clin Microbiol; 2004 Dec; 42(12):5885-8. PubMed ID: 15583332
[TBL] [Abstract][Full Text] [Related]
16. Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus.
He Q; Manopo I; Lu L; Leung BP; Chng HH; Ling AE; Chee LL; Chan SW; Ooi EE; Sin YL; Ang B; Kwang J
Clin Diagn Lab Immunol; 2005 Feb; 12(2):321-8. PubMed ID: 15699428
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing antibodies in patients with severe acute respiratory syndrome-associated coronavirus infection.
Nie Y; Wang G; Shi X; Zhang H; Qiu Y; He Z; Wang W; Lian G; Yin X; Du L; Ren L; Wang J; He X; Li T; Deng H; Ding M
J Infect Dis; 2004 Sep; 190(6):1119-26. PubMed ID: 15319862
[TBL] [Abstract][Full Text] [Related]
18. Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients.
Wang Y; Chang Z; Ouyang J; Wei H; Yang R; Chao Y; Qu J; Wang J; Hung T
DNA Cell Biol; 2005 Aug; 24(8):521-7. PubMed ID: 16101351
[TBL] [Abstract][Full Text] [Related]
19. Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes.
Temperton NJ; Chan PK; Simmons G; Zambon MC; Tedder RS; Takeuchi Y; Weiss RA
Emerg Infect Dis; 2005 Mar; 11(3):411-6. PubMed ID: 15757556
[TBL] [Abstract][Full Text] [Related]
20. Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients.
Cao Z; Liu L; Du L; Zhang C; Jiang S; Li T; He Y
Virol J; 2010 Nov; 7():299. PubMed ID: 21047436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
